Swissmedic approves the use of the monoclonal antibody cocktail Ronapreve developed by Roche and Regeneron to treat severe COVID-19 patients. (Swissinfo) COVID-19 pandemic in Switzerland, COVID-19 drug developmentCOVID-19 pandemic link embed save